Sustainability Report

Overview

The report describes CR Pharmaceutical's 2021 sustainability strategy, with the Board of Directors holding full responsibility for ESG strategy and an ESG Committee reporting to the Board. It highlights HK$ 236,806.17 million in revenue and 64,950 employees. Environmental disclosures include 648,394.79 ton of CO2 emissions, while the company reports 100% employee training coverage and zero work-related fatalities. The report also details the Healthy Village Program, green operations, supplier audits, employee care, and public-welfare and disaster-relief initiatives.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2021
Period: 1 January 2021 – 31 December 2021
Language: English
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP
Other

Ratings

GRI level

Materiality

Assessment
Basis
Matrix

Assurance

Standard
Scope
Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services

Overview